Pfizer And BioNtech Begin Clinical Trial For Omicron-Specific COVID-19 Vaccine

0

Pfizer and BioNTech have started a clinical trial for their Omicron-specific COVID-19 vaccine.

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *